Pitavastatin Magnesium Patent Expiration

1. Zypitamag patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8829186 MEDICURE Method for preparation of pitavastatin and pharmaceutical acceptable salts thereof
Jan, 2031

(6 years from now)

Market Authorisation Date: 14 July, 2017

Treatment: NA

Dosage: TABLET

More Information on Dosage

ZYPITAMAG family patents

Family Patents